Ann Arbor, MI, United States of America

Brandon H McNaughton

This inventor holds 17 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Akadeum Life Sciences, Inc., University of Michigan. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brandon H McNaughton. Retrieved from https://idiyas.com/inventor/brandon-h-mcnaughton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 43(Granted Patents)


Location History:

  • Ypsilanti, MI (US) (2014 - 2015)
  • Ann Arbor, MI (US) (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Inventor Brandon H McNaughton

Introduction: Brandon H McNaughton is a talented inventor based in Ann Arbor, MI (US) known for his innovative contributions in various fields.

Latest Patents: Brandon H McNaughton holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Brandon H McNaughton has successfully brought several groundbreaking inventions to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Brandon H McNaughton has collaborated with leading researchers, engineers, and companies to further develop and refine his inventions, ensuring their success and impact.

Conclusion: Brandon H McNaughton's dedication to innovation and his ability to think outside the box make him a standout inventor in the field, with a promising future ahead.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…